Fig. 7: Single-cell RNA-seq analyses of tumor-infiltrating leukocytes. | Nature Immunology

Fig. 7: Single-cell RNA-seq analyses of tumor-infiltrating leukocytes.

From: Simultaneous STING and lymphotoxin-β receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity

Fig. 7

Tumor-infiltrating CD45+ cells were analyzed on day 14 by single-cell RNA-seq following FACS sorting. a, Left: uniform manifold approximation and projection (UMAP) of different CD45+ leukocyte populations was generated using sets of genes for cell-type annotations as listed in Extended Data Fig. 9. Right: relative abundance of different immune cell types is shown as the fractions of total tumor-infiltrating CD45+ leukocytes in indicated treatment groups. b, Each B cell subtype was identified by expression of indicated marker genes. PC, plasma cell; LPC, long-lived plasma cell. c, Upper plots: the abundance of intratumoral B cell subtypes in different treatment groups. Lower plots: the abundance of intratumoral B cell populations expressing different isotypes of immunoglobulins. df, Intratumoral CD4+ T cell subtypes (naive, TH1, TH2 and TH17) are shown as separate clusters in the t-SNE plots of different treatment groups (d). The identity of each T cell subtype was determined by the expression of indicated marker genes (e). The relative abundance of CD4+ T cell subtypes is shown as the fraction of total intratumoral CD4+ T cells in different treatment groups (f). DC, dendritic cell.

Back to article page